Watch PDSB. Know when insiders buy.
One email the day a filing lands. Free.
PDSB
PDS Biotechnology Corp
1.11
−0.05 −4.31%
USD · close Oct 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
2
FLAG · shorts 2
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $62.1MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$33.7MNET DEBT $9.4M52W 0.20 – 1.60SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose PDSB in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Nant Capital, LLC and 1 related19.9%
“The information set forth in Item 3 of this Schedule is incorporated herein by reference. The Reporting Person acquired their shares of Common Stock, Pre-Funded Warrants and Common Warrants as an investment in the ordinary course of business. At the Milestone Closing, which will be triggered by the…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.